UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The role of human endogenous retroviruses in melanoma

British journal of dermatology (1951), 2009-12, Vol.161 (6), p.1225-1231

2009

Volltextzugriff (PDF)

A feasibility study of sequential doublet chemotherapy comprising carboplatin–doxorubicin and carboplatin–paclitaxel for advanced endometrial adenocarcinoma and carcinosarcoma

Annals of oncology, 2009-11, Vol.20 (11), p.1787-1793

2009

Volltextzugriff (PDF)

Cutaneous adverse events associated with vemurafenib in patients with metastatic melanoma: practical advice on diagnosis, prevention and management of the main treatment-related skin toxicities

British journal of dermatology (1951), 2012-11, Vol.167 (5), p.987-994

2012

Volltextzugriff (PDF)

Pathogenesis, clinical evolution and outcomes of patients with immune checkpoint inhibitor induced acute liver injury: A multicentre study

Annals of oncology, 2018-10, Vol.29, p.viii430-viii430

2018

Volltextzugriff (PDF)

MEDIOLA: A phase I/II trial of olaparib (PARP inhibitor) in combination with durvalumab (anti-PD-L1 antibody) in pts with advanced solid tumours - new ovarian cancer cohorts

Annals of oncology, 2018-10, Vol.29 Suppl 8, p.viii147

2018

Volltextzugriff (PDF)

881PDIMPLEMENTATION OF ROUTINE BRCA GENE TESTING OF OVARIAN CANCER (OC) PATIENTS AT ROYAL MARSDEN HOSPITAL

Annals of oncology, 2014-09, Vol.25 (suppl_4), p.iv307-iv307

2014

Volltextzugriff (PDF)

902POVARIAN CARCINOSARCOMA MANAGEMENT: A RETROSPECTIVE ANALYSIS OF THE ROYAL MARSDEN EXPERIENCE

Annals of oncology, 2014-09, Vol.25 (suppl_4), p.iv314-iv314

2014

Volltextzugriff (PDF)

Implementation of Routine Brca Gene Testing of Ovarian Cancer (Oc) Patients at Royal Marsden Hospital

Annals of oncology, 2014-09, Vol.25, p.iv307

2014

Volltextzugriff (PDF)

Ovarian Carcinosarcoma Management: a Retrospective Analysis of the Royal Marsden Experience

Annals of oncology, 2014-09, Vol.25, p.iv314

2014

Volltextzugriff (PDF)

Clinical Outcomes of Recurrent Ovarian Granulosa Cell Tumours Treated with Letrozole: a 10-Year Retrospective Case-Series of the Royal Marsden Hospital

Annals of oncology, 2014-09, Vol.25, p.iv305

2014

Volltextzugriff (PDF)

877PDCLINICAL OUTCOMES OF RECURRENT OVARIAN GRANULOSA CELL TUMOURS TREATED WITH LETROZOLE: A 10-YEAR RETROSPECTIVE CASE-SERIES OF THE ROYAL MARSDEN HOSPITAL

Annals of oncology, 2014-09, Vol.25 (suppl_4), p.iv305-iv306

2014

Volltextzugriff (PDF)

Mucinous ovarian cancer

International journal of gynecological cancer, 2008-03, Vol.18 (2), p.209-214

2008

Volltextzugriff (PDF)

Vegetative Compatibility and Pathogenicity of Verticillium dahliae Isolates from the Aegean Region of Turkey

Phytoparasitica, 2007, Vol.35 (3), p.222-231

Gore, M.E

2007

Volltextzugriff (PDF)

Second primary melanomas on treatment with vemurafenib: reply from the authors: Correspondence

British journal of dermatology (1951), 2013-04, Vol.168 (4), p.888-889

2013

Volltextzugriff (PDF)

Interim Results of a Phase II Study of Sunitinib and Low Dose Metronomic Cyclophosphamide in Advanced Renal Cell Cancer

Annals of oncology, 2012-09, Vol.23, p.ix273-ix274

2012

Volltextzugriff (PDF)

972PD - Efficacy of Platinum Plus Gemcitabine (G) in Platinum-Resistant (R) Compared to Platinum-Sensitive (S) Ovarian Cancer: the Royal Marsden Experience

Annals of oncology, 2012-09, Vol.23, p.ix320-ix320

2012

Volltextzugriff (PDF)

Efficacy of Platinum Plus Gemcitabine (G) in Platinum-Resistant (R) Compared to Platinum-Sensitive (S) Ovarian Cancer: the Royal Marsden Experience

Annals of oncology, 2012-09, Vol.23, p.ix320

2012

Volltextzugriff (PDF)

A Phase 1, Dose Escalation Study of Paclitaxel with Gsk1120212 (Trametinib) for the Treatment of Advanced Melanoma

Annals of oncology, 2014-09, Vol.25, p.iv379

2014

Volltextzugriff (PDF)

1094PDA PHASE 1, DOSE ESCALATION STUDY OF PACLITAXEL WITH GSK1120212 (TRAMETINIB) FOR THE TREATMENT OF ADVANCED MELANOMA

Annals of oncology, 2014-09, Vol.25 (suppl_4), p.iv379-iv379

2014

Volltextzugriff (PDF)

U.K. guidelines for the management of cutaneous melanoma

British journal of dermatology (1951), 2002-01, Vol.146 (1), p.7-17

2002

Volltextzugriff (PDF)

Cutaneous adverse events associated with vemurafenib in patients with metastatic melanoma: practical advice on diagnosis, prevention and management of the main treatment-related skin toxicities: Cutaneous adverse events with vemurafenib: practical advice

British journal of dermatology (1951), 2012-11, Vol.167 (5), p.987-994

2012

Volltextzugriff (PDF)

Temsirolimus in the treatment of advanced renal cell carcinoma

Annals of oncology, 2007-07, Vol.18 (suppl-9), p.ix87-ix88

Gore, ME

2007

Volltextzugriff (PDF)

Axitinib vs Sorafenib for Advanced Renal Cell Carcinoma: Phase III Overall Survival Results and Analysis of Prognostic Factors

Annals of oncology, 2012-09, Vol.23, p.ix262

2012

Volltextzugriff (PDF)

Sunitinib Global Expanded-Access Trial in Metastatic Renal Cell Carcinoma (MRCC) – Final Results

Annals of oncology, 2012-09, Vol.23, p.ix271

2012

Volltextzugriff (PDF)

Bevacizumab (BEV) + Low-Dose Interferon-α2A (IFN) for First-Line Treatment of Metastatic Renal Cell Carcinoma (MRCC): Final Safety and Efficacy Data from the Prospective Bevlin Study

Annals of oncology, 2012-09, Vol.23, p.ix267

2012

Volltextzugriff (PDF)

1 – 25 von 62

Suche als RSS-Feed

Aktive Filter

KollektionElsevier ScienceDirect Journals Complete

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(54)
Mit Volltextzugriff
(57)

Publikationsform

Artikel
(61)
Dissertationen
(1)

Sprache

Englisch
(61)
Afrikaans
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(35)
Life Sciences & Biomedicine
(34)
Humans
(25)
Biological And Medical Sciences
(23)
Medical Sciences
(22)
Female
(17)
Adult
(13)
Middle Aged
(13)
Oncology
(12)
Aged
(11)
Dermatology
(10)
Male
(10)
Antineoplastic Agents
(9)
Pharmacology. Drug Treatments
(9)
Tumors Of The Skin And Soft Tissue. Premalignant Lesions
(8)
Plant Sciences
(7)
Chemotherapy
(6)
Tumors
(6)
Agriculture
(5)
Agronomy
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The role of human endogenous retroviruses in melanoma

A feasibility study of sequential doublet chemotherapy comprising carboplatin–doxorubicin and carboplatin–paclitaxel for advanced endometrial adenocarcinoma and carcinosarcoma

Cutaneous adverse events associated with vemurafenib in patients with metastatic melanoma: practical advice on diagnosis, prevention and management of the main treatment-related skin toxicities

Pathogenesis, clinical evolution and outcomes of patients with immune checkpoint inhibitor induced acute liver injury: A multicentre study

MEDIOLA: A phase I/II trial of olaparib (PARP inhibitor) in combination with durvalumab (anti-PD-L1 antibody) in pts with advanced solid tumours - new ovarian cancer cohorts

881PDIMPLEMENTATION OF ROUTINE BRCA GENE TESTING OF OVARIAN CANCER (OC) PATIENTS AT ROYAL MARSDEN HOSPITAL

902POVARIAN CARCINOSARCOMA MANAGEMENT: A RETROSPECTIVE ANALYSIS OF THE ROYAL MARSDEN EXPERIENCE

Implementation of Routine Brca Gene Testing of Ovarian Cancer (Oc) Patients at Royal Marsden Hospital

Ovarian Carcinosarcoma Management: a Retrospective Analysis of the Royal Marsden Experience

Clinical Outcomes of Recurrent Ovarian Granulosa Cell Tumours Treated with Letrozole: a 10-Year Retrospective Case-Series of the Royal Marsden Hospital

877PDCLINICAL OUTCOMES OF RECURRENT OVARIAN GRANULOSA CELL TUMOURS TREATED WITH LETROZOLE: A 10-YEAR RETROSPECTIVE CASE-SERIES OF THE ROYAL MARSDEN HOSPITAL

Mucinous ovarian cancer

Vegetative Compatibility and Pathogenicity of Verticillium dahliae Isolates from the Aegean Region of Turkey

Second primary melanomas on treatment with vemurafenib: reply from the authors: Correspondence

Interim Results of a Phase II Study of Sunitinib and Low Dose Metronomic Cyclophosphamide in Advanced Renal Cell Cancer

972PD - Efficacy of Platinum Plus Gemcitabine (G) in Platinum-Resistant (R) Compared to Platinum-Sensitive (S) Ovarian Cancer: the Royal Marsden Experience

Efficacy of Platinum Plus Gemcitabine (G) in Platinum-Resistant (R) Compared to Platinum-Sensitive (S) Ovarian Cancer: the Royal Marsden Experience

A Phase 1, Dose Escalation Study of Paclitaxel with Gsk1120212 (Trametinib) for the Treatment of Advanced Melanoma

1094PDA PHASE 1, DOSE ESCALATION STUDY OF PACLITAXEL WITH GSK1120212 (TRAMETINIB) FOR THE TREATMENT OF ADVANCED MELANOMA

U.K. guidelines for the management of cutaneous melanoma

Cutaneous adverse events associated with vemurafenib in patients with metastatic melanoma: practical advice on diagnosis, prevention and management of the main treatment-related skin toxicities: Cutaneous adverse events with vemurafenib: practical advice

Temsirolimus in the treatment of advanced renal cell carcinoma

Axitinib vs Sorafenib for Advanced Renal Cell Carcinoma: Phase III Overall Survival Results and Analysis of Prognostic Factors

Sunitinib Global Expanded-Access Trial in Metastatic Renal Cell Carcinoma (MRCC) – Final Results

Bevacizumab (BEV) + Low-Dose Interferon-α2A (IFN) for First-Line Treatment of Metastatic Renal Cell Carcinoma (MRCC): Final Safety and Efficacy Data from the Prospective Bevlin Study

Aktive Filter

Suchergebnisse filtern